Abstract
Background and Introduction
Piroxicam is an NSAID (non-steroidal anti-inflammatory drug) persisting antipyretic and analgesic effects and being usually implied in managing and treating osteoarthritis, rheumatoid arthritis, soft tissue disorders, ankylosing spondylitis, and acute gout and also in post-operative pain management.
Aim
The present research was undertaken aiming to formulate Piroxicam encompassing floating oral in situ gels, in order to augment its anti-inflammatory activity and to alleviate its gastric ulceration potential.
Materials and Methods
In the present work, a three-factor at two-level (23) factorial design was adopted to inspect the effects of three factors viz. sodium alginate [A], sodium bicarbonate [B], and sodium citrate [C] on the dependent variables like in vitro gelation, in vitro floating, percentage water uptake, and percentage drug release.
Results
All the formulations have exhibited pH ranging from 6.7 ± 0.25 to 7.4 ± 0.24. Percentage drug content was noted in the range of 96.3 ± 0.27 to 99.5 ± 0.28%. In vitro gelation was instantaneous post administration of the system, which remained intact for an extended time period. Percentage water uptake was in the range 9.01 ± 0.15 to 31.01 ± 0.25%; floating lag time was estimated around 7 ± 0.39 to 57 ± 0.36 s. Formulations F4 and F5 reflected floating even past 12 h. All the formulations have exhibited drug release of around 90% within 8 h. It was experiential that the chosen independent variables had significant effect on the dependent variables, justifying the robustness and aptness of design implied for optimization.
Conclusions
The developed system may be a promising and alternative strategy to augment gastric retention of Piroxicam, thereby increasing its therapeutic efficacy. It even offers additional benefit of reducing the gastric irritation, tissue damage, and ulceration, by avoiding direct contact of drug with mucosa of stomach.
Similar content being viewed by others
References
Chaudhary H, Rohilla A, Rathee P, Kumar V. Optimization and formulation design of carbopol loaded piroxicam gel using novel penetration enhancers. Int J Biol Macromol. 2013;55:246–53. https://doi.org/10.1016/j.ijbiomac.2013.01.015.
Karataş A, Yüksel N, Baykara T. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol. Il Farmaco. 2005;60(9):777–82. https://doi.org/10.1016/j.farmac.2005.04.014.
Maharjan R, Subedi G. Formulation and evaluation of floating in-situ gel of ranitidine using natural polymers. Int J Pharm Pharm Sci. 2014;6(10):205–9.
Jafar M, Salahuddin M, Bolla SR. Gastric floating in-situ gel as a strategy for improving anti-inflammatory activity of meloxicam. J App Pharm Sci. 2018;8(11):95–102. https://doi.org/10.7324/japs.2018.81114.
Anyanwu NC, Adogo LY, Ajide B. Development and evaluation of in-situ gelling gastroretentive formulations of Meloxicam. Univ J Pharm Res. 2017;2(3):11–4. https://doi.org/10.22270/ujpr.v2i3.r3.
Shamsuddin MF, Ansari SH, Ali J. Development and evaluation of solid dispersion of spironolactone using fusion method. Int J Pharm Investig. 2016;6(1):63–8. https://doi.org/10.4103/2230-973x.176490.
Wamorkar V, Varma MM, Manjunath SY. Formulation and evaluation of stomach specific in-situ gel of metoclopramide using natural, bio-degradable polymers. Int J Res Pharmaceut Biomed Sci. 2011;2(1):193–201.
Mamdouh M, Donia A, Essa E, Maghraby GE. Preparation of liquid oral mucoadhesive gastro-retentive system of nimodipine. Curr Drug Deliv. 2019;16(9):862–71. https://doi.org/10.2174/1567201816666191014102531.
Osmani RA, Kulkarni PK, Shanmuganathan S, Hani U, Srivastava A, Prerana M, et al. A 32 full factorial design for development and characterization of a nanosponge-based intravaginal in-situ gelling system for vulvovaginal candidiasis. RSC Adv. 2016;6(23):18737–50. https://doi.org/10.1039/c5ra26218f.
Hani U, Shivakumar HG, Srivastava A, Mahammed N, Thirumaleshwar S. kumar Varma NS, Vaghela R, Shinde CG, Gowrav MP. Design and optimization of curcumin–hpβcd bioadhesive vaginal tablets by 23 factorial design: in-vitro and in-vivo evaluation. J Pharm Innov. 2015;10(1):21–35. https://doi.org/10.1007/s12247-014-9203-4.
Kyada C, Ranch K, Shah D. Optimization of mucoadhesive microspheres of acyclovir by applying 32 full factorial design. J Drug Deliv Sci Tech. 2014;24(1):61–8. https://doi.org/10.1016/s1773-2247(14)50009-3.
Bothiraja C, Kumbhar V, Pawar A, Shaikh K, Kamble R. Development of floating in-situ gelling system as an efficient anti-ulcer formulation: in-vitro and in-vivo studies. RSC Adv. 2015;5(37):28848–56. https://doi.org/10.1039/c5ra01575h.
Kumar KK, Swathi M, Srinivas L, Basha N. Formulation and evaluation of floating in-situ gelling system of losartan potassium. Pharm Lett. 2015;7:98–112.
Nagarwal RC, Srinatha A, Pandit JK. In-situ forming formulation: development, evaluation, and optimization using 33 factorial design. AAPS PharmSciTech. 2009;10(3):977–84. https://doi.org/10.1208/s12249-009-9285-3.
Gajanan S, Shankar D, Suresh J, Dushyant G. Design and optimization of in-situ floating gel containing ondansetron hydrochloride dihydrate using 32 factorial design. Pharm Innov. 2017;6(1, Part B):83.
Aglawe SB. Formulation and evaluation of gastroretentive floating dosage form of nizatidine. World J Pharm Pharm Sci. 2017:1345–52. https://doi.org/10.20959/wjpps20179-10035.
Obiedallah MM, Abdel-Mageed AM, Elfaham TH. Ocular administration of acetazolamide microsponges in-situ gel formulations. Saudi Pharm J. 2018;26(7):909–20. https://doi.org/10.1016/j.jsps.2018.01.005.
Nagendra R, Pai RS, Singh G. Design and optimization of novel in-situ gel of mercaptopurine for sustained drug delivery. Braz J Pharm Sci. 2014;50(1):107–19. https://doi.org/10.1590/s1984-82502011000100011.
Mahagen Y, Patidhar V, Balaram Y, Gopkumar P, Sridevi G. Formulation and evaluation of floatable in-situ gel for stomach-specific drug delivery of carbamazapine. J Pharm Pharm Sci. 2014;3(1):37–43.
Patel RP, Dadhani B, Ladani R, Baria AH, Patel J. Formulation, evaluation and optimization of stomach specific in-situ gel of clarithromycin and metronidazole benzoate. Int J Drug Deliv. 2010;2(2):141–53. https://doi.org/10.5138/ijdd.2010.0975.0215.02023.
Chen N, Li Q, Li J, Ren Y, Wu G, Liu Y, et al. Development and evaluation of a new gastroretentive drug delivery system: Nanomicelles-loaded floating mucoadhesive beads. J Drug Deliv Sci Tech. 2019;51:485–92. https://doi.org/10.1016/j.jddst.2019.03.024.
Paradkar MU, Parmar M. Formulation development and evaluation of Natamycin niosomal in-situ gel for ophthalmic drug delivery. J Drug Deliv Sci Tech. 2017;39:113–22. https://doi.org/10.1016/j.jddst.2017.03.005.
Gharti KP, Budhathoki U, Thapa P, Bhargava A. Formulation and in-vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. J Young Pharm. 2012;4(4):201–8. https://doi.org/10.4103/0975-1483.104363.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hani, U., Osmani, R.A.M., Alqahtani, A. et al. 23 Full Factorial Design for Formulation and Evaluation of Floating Oral In Situ Gelling System of Piroxicam. J Pharm Innov 16, 528–536 (2021). https://doi.org/10.1007/s12247-020-09471-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12247-020-09471-z